Risk & reward: Longevity investmentsAuthor: Phil Newman | Published on: April 30, 2020 | Last updated: May 10, 2022 Ronjon NagManaging Director and Founder, R42 GroupRisk & reward: longevity investments Share this article: Editor's choiceEmpowering cells to boost energy and recovery is a winning moveStudy disproves benefits of probiotics for vaginal healthHow do Tour De France athletes recover so fast? Performance coach reveals the secret9 proven ways to beat brain fog and enhance your energyLongevity investment platform opens-up to international investorsUrolithin A research opens door to osteoarthritis relief Popular articlesTelocyte’s gene therapy funded through to clinical trialsLongevity investment bulletin: Insilico Medicine, Biophytis, Synartro and moreBuck Institute launches first human clinical trial into ketone body supplementationNew test could detect Alzheimer’s disease 3.5 years before clinical diagnosisThe small molecule with a big futureLongevity investment bulletin: Global funding revealed, new SPAC, Recursion, Celularity and more
